OMCL
HOLD / NEUTRALMeanRevComposite
54.60
Technical
34.50
Fundamental
61.30
Rank
—
Price
37.11
Hurst
0.29
As of
Jul 31, 2026
Daily
Omnicell, Inc.
HealthcareHealth Information ServicesOmnicell develops healthcare technology solutions for hospitals and health systems globally. Its offerings include automated medication dispensing systems, pharmacy automation services for central and specialty pharmacies, IV compounding equipment, and digital platforms that enhance medication management and adherence. The company also provides software and hardware for tracking medicines and supplies throughout healthcare facilities, along with professional services including implementation, training, and ongoing technical support.
Market cap
$1.5B
P/E (trailing)
38.83
P/E (forward)
15.61
PEG ratio
15.40
Dividend yield
—
Beta
0.97
52w range
29.06 – 55.00
Return on equity
+3.06%
Profit margin
+3.14%
Revenue growth
+7.50%
Earnings growth
+333.30%
Price history
1Y: 32.62 (+2.6%) · range 29.46–51.39
Cycle position
15/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 79 · GOOD SETUP · exit proximity 0
Conviction
37/ 100 · maturity 100%
VScore.403
Buildup.2036
EMA entry setup.2579
Fundamentals.1561
Volume profile
POC
37.13
Price vs POC
-12.2%
Overhead supply
98%
Runway
+11.8%
Value area 34.03–43.82 · 98% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.033 | Aug 28, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -6.63% | +2.25% | mature |
| 40d | -10.92% | +2.25% | 24/40d |